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Abstract  
 
The spasmolytic properties of the aqueous extract of Aframomum melegueta (K Schum) and Citrus aurantifolia 
(Christm and Panzer) (AMCA) mixture were tested on isolated rat trachea.  Inhibition of the contraction was observed the in 
presence of the AMCA (EC 50 = 1.80 ± 0.48 mg/mL) after a pre contraction of the trachea by acetylcholine (10 
-5 
M).  With 
propranolol (10 
-6 
M), the spasmolytic activity of the mixture was inhibited and the concentration-response curve shifted to the 
right.  The EC50 value was then 2.60 ± 0.41 mg/mL. AMCA also inhibited contraction induced by KCl (4.10 
-2 
M) with EC50 
value = 1.86 ± 0.65 mg/mL.  These results clearly show the relaxing effect of the aqueous extract on the isolated rat trachea. This 
effect involved some β-adrenergic receptor inhibition. 
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Introduction  
 
Aframomum melegueta  (K Schum) is widespread in the forest areas of Gabon, Congo, Islands of the Gulf of Guinea, 
Cameroun and in Western Africa and it was cultivated in the shaded mediums (Kamtchouing et al.2002).  In Africa, Aframomum 
melegueta is very popular in many cookings as condiment and is also used for ritual purposes. It is strongly used in traditional 
medicine and African pharmacopeia, in the treatment of several diseases such us intestinal infections (Kempkes, 1995) and 
heartburn; Aframomun melegueta also effective in indigestions due to the fact that it stimulates the gastric secretions. In the same 
way, it is an aphrodisiac (Umukoro and Ashorobi , 2003). In Benin, it is mixed with other plants for the treatment of several 
pathologies (Adjanohoun, 1986).    
Citrus aurantifolia (Christm and Panzer) is cultivated everywhere in the world.  The fruit is collected before maturity 
for food and medicinal use; It was used in particular against obesity, asthma, hypertension, and measles.  In this work, we studied 
the spasmolytic effect of the total aqueous extract from the mixture of Aframomum melegueta (K Schum) and Citrus aurantifolia 
(Christm and Panzer) (AMCA) on the isolated rat trachea.  This study aimed to identify the pharmacological properties justifying 
the traditional use of this mixture in the treatment of asthma.   
 
 
 
Material and Methods  
Plant materials 
 
Aframomum melegueta was collected in Adjarra, locality in the Department of Ouémé in Benin in June 2009.   The 
harvest of the sheets and fruits of Citrus aurantifolia was collected in August 2009 at Ouando located in the same department.  
The identification was made by the National Herbarium of the University of Abomey-Calavi of Benin. Each specimen was 
deposited at the University (Voucher N° AA6374/HNA for Aframomum melegueta (Roscoe) K. Schum. and AA6375/HNB for 
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Citrus aurantifolia (Christm. et Panzer) Swingle. The total aqueous extract was prepared by mixing 125g of Aframomum 
melegueta seeds with the filtrate obtained from Citrus aurantifolia 125g of leaves and 290g of fruits in 1 liter of distilled water. 
After 5 hours of stirring, the mixture was filtered, centrifuged and lyophilized (Huet, 1991; Houghton and Amala, 1998). 
 
Animals  
 
Male Wistar rats (weight 288.02 ± 13.41 g) were used.  The animals were fasted 18 hours before the test.  They were 
then anaesthetized with urethane (1.5 g/kg of body weight intravenously). The respiratory tract was then and transferred in a 
sterile container containing a physiological solution from Krebs (Loenders et al., 1992).  Wistar rats used in this study were 
handled according to the Institutional animal safety guidelines (University of Abomey Calavi, Benin and the Animal Company of 
Human Biology Unit, Health Science Faculty, University of Abomey Calavi, Benin). Animal experiments were approved by the 
National Health Ethics Committee of Benin (www.ethique-sante.org) under the following registration N°: 
002_084/MS/DC/SGM/DFRS/-CNPERS/SA.  
 
Solutions and drugs  
 
The solution of Krebs used was made up of:  NaCl,  6.9g;  NaHCO3 , 2.02g;  KCl  (LABOSI P 1295 1 kg Batch 
083151) 0.35g;  KH2PO4,  0.16g;   MgSO4,  0.30g;  CaCl2,  0.37g;  D-glucose, 0.6 g in 1L of distilled water.  Drugs used were 
diluted in distilled water.  It was about: acetylcholine (SIGMA A-2661 100 g Batch 35H07845) 10 
-5
M, propranolol 10 
-6 
M, 
KCl 4.10 
-2 
M; the cumulative dose of atropine were also used.  The total aqueous extract of Aframomum melegueta – Citrus 
aurantifolia mixture was used with a cumulative amount after the period of balancing.   
 
Preparation and mounting  
 
The thoracic trachea was transected between the segments of cartilage (4 to 5 rings).  These rings were then assembled 
in the isolated organ bath container of 20 ml from modified krebs solution at 37° C and bubbled with a mixture of oxygen (95%), 
carbon dioxide (5%)(Schramm, 2000). The ring of the trachea was fixed between one triangular support fixed inside the bath and 
the other one was connected to the transducer.  The preparation was subjected to a tension ranging between 300 mg and 500 mg, 
during 1 h to obtain regular and spontaneous contractions (Van and Hulsmann , 1999). It was then balanced gradually to a tension 
of 1.5 g during 30 min. During these 90 min of incubation, a wash was carried out every 15 min. The transducer used for the 
recording was isometric of F50 type EMKA.  It was connected to an analogical amplifier (EMKA). The graphic recording was 
obtained by the software of acquisition U-vessel (WAGNER University of Strasbourg, France).   
 
Methods  
 
AMCA was used with a cumulative concentration after the 90 min of equilibration period. The Drugs tested were 
introduced directly into the isolated organ bath using a micro syringe.  The volume of administration did not exceed 5% of the 
volume of the bath (Kouloumenta et al., 2006). The first stimulation was carried out by an injection of acetylcholine (10 
-5
M) in 
the isolated organ tank.  For a relaxation test, a second stimulation was done.  When the contraction reached a maximal effect, the 
AMCA was added in a cumulative concentration manner. In order to check an implication of the β-adrenergic receptor in the 
relaxing activity of the extract, propranolol (10
-6 
M) was used. The anti-spasmolytic effect of atropine was examined as a 
reference. This drug was added in cumulative pattern into the bath 15 min after the administration of acetylcholine. The Effect of 
AMCA was expressed as a percentage (%) of relaxation. The concentration-response curves were plotted and the effective 
concentrations of 50% were noted.  
 
Statistical analysis  
 
Concentration-response curves and EC50 were determined by GraphPad Prism version 2.01 Demo.. The student’s  t - 
test was used for the comparisons between each group.  The data were expressed in the form of mean ± SEM. The probability of 
(p) error was regarded as significant with p < 0.05.  
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Results and discussion  
 
The maximal contractile response to acetylcholine (10 
-5
M) amounted to 4.00 ± 0.30 g (Table1).  AMCA (0.03-14 
mg/mL) inhibited in a concentration-dependent way, the contraction developed by acetylcholine (Figure 1). The maximal effect 
(94 .98 ± 2.85%) was observed with 14 mg/mL concentration. EC50 value was 1.80 ± 0.48 (table1). Atropine (10-8-10-7M) 
abolished acetylcholine spasmogenic effect.  
It is well known that acetylcholine causes a contraction through muscarinic receptor in tracheal smooth muscles; 
however this effect was inhibited by atropine (Aruniakshana et al., 1959). The Relaxation on the tracheal smooth muscle can also 
occur by β-adrenergic receptor stimulation (Torphy et al., 1983; Kume and Kotilkoff, 1991). We examined the relative 
contribution of β-adrenergic receptor in AMCA-induced relaxation.  
The addition of propranolol (10
-6 
M) in the organ bath, slightly influenced AMCA decreased tension developed by 
acetycholine (10-6 M) (compare solid square and triangle in figure 1); EC50 value was then 2.60 ± 0.41 mg/mL (Table 1). Indeed 
β-adrenergic receptors inhibition by propranolol (10-6 M) shifted the concentration-response curve to AMCA to the right as 
regard to the control.   
 
 
 
 
 
Table 1: Values of maximal contraction, EC50 and Emax 
 
 Effectif 
(n) 
Maximal contraction 
(g) 
EC50 (mg/mL) Emax  
(%) 
 
Acetylcholine 
 
5 
 
4. 00 ± 0.3 
 
1.80 ± 0.48 
 
94 .98 ± 2.85 
 
Propranolol 
 
7 
 
4. 00 ± 0.3 
 
2.60  ± 0.41 
 
88.55 ± 2.74 
 
KCL 
 
6 
 
4.2 ± 0,26 
 
1.86 ± 0.65 
 
98.24 ±1,76 
 
Atropine 5    1.22 ± 0.02 - - 
 
 
 
 
The Physiological antagonism between β-adrenergic muscarinic receptors was well established on a rat bronchial tissue. These 
results are comparable with those obtained by Torphy and Cielslinkski (1990) and Kume and Kotilkoff  (1991). The stimulation 
of β2–adrenergic receptor increases the cyclic Adenosine monophosphate (cAMP) concentration which in turn decreases the 
intracellular level of calcium Ca2+ concentration and then induces smooth muscle relaxation. The Membrane potential regulates 
smooth muscle contractility by modification of calcium flow through voltage dependent calcium channels (Nelson et al., 1990). 
We assessed AMCA influence on calcium mobilization through KCL-induced smooth muscle contraction 
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Figure 1:  Effect of the AMCA on the contraction induced by Acetylcholine 10 -5 M (Point) and in the presence of propranolol 
10 
-6 
M (triangle).  Each point represents the mean and the standard deviation.  (N:  5-7)  
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Figure 2:  Effect of AMCA on the contraction induced by Acetylcholine 10 
-5 
M (square) and KCl 4.10 
-2 
M (triangle).  Each 
point represents the mean and the standard deviation.  (N:  5-7)  
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The maximal contractile response to KCl (4.10 
-2 
M) amounted to 4.20 ± 0.26g (Table1). AMCA inhibits KCL-induced- 
contraction in concentration-dependent manner (Figure 2).  EC50 value was 1.86 ± 0.65 mg/mL. KCl induced depolarization of 
smooth muscle cells and this depolarization led to an opening of calcium voltages dependent channels.  This mechanism enhances 
cellular calcium concentration and induces contraction (Nelson et al., 1990). So the relaxation effect of AMCA on these two 
contractile agents (Acetylcholine and KCL) was similar (see EC50 on acetylcholine and KCL-induced contraction) (Table 1). 
These results indicate that AMCA effect was not only cholinolytic, but also inhibited calcium mobilization.   Our results 
corroborate those of Ouédraogo (2009), which showed that the relaxing effect of Calotropis procera Ait.on the trachea isolated 
from a rabbit involved interaction with calcium.   
  
Conclusion  
 
Our results revealed relaxing properties of AMCA on tracheal smooth muscle isolated from a rat.  The extract did not 
involve muscarinic receptor but likely inhibited cellular calcium. It also involved in part, β-adrenergic receptors. 
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